SCHEMBL2415759

SCHEMBL2415759

CCc1cnc(N(CCOc2ccc(OC)cc2)CCc2csc(SC(C)(C)C(=O)O)n2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.39
MAPT P10636 3/20 0.38
TP53 P04637 1/20 0.38
PPARD Q03181 3/20 0.35
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
SLC22A12 Q96S37 1/20 0.34
HSP90AA1 P07900 1/20 0.34
PPARG P37231 3/20 0.33
POLB P06746 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
MCHR1 Q99705 1/20 0.33
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ATP4A P20648 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2409301 0.97 PPARA (0.39) PPARAMAPTTP53PPARDALDH1A1
SCHEMBL2411363 0.95 PPARA (0.39) PPARAMAPTTP53PPARDSLC22A12
SCHEMBL2415868 0.93 PPARA (0.38) PPARAPPARDNPC1RAB9APPARG
SCHEMBL2415503 0.93 PPARG (0.37) PPARAPPARDNPC1RAB9AKDM4E
SCHEMBL2419764 0.93 PPARA (0.37) PPARATP53PPARDRAB9AKDM4E
SCHEMBL2416272 0.93 PPARA (0.37) PPARAMAPTTP53PPARDNPC1
SCHEMBL2412377 0.93 PPARA (0.37) PPARAMAPTTP53PPARDALDH1A1
SCHEMBL12274384 0.90 PPARA (0.38) PPARAMAPTTP53PPARDNPC1
SCHEMBL2415449 0.90 PPARA (0.37) PPARAPPARDALDH1A1NPC1RAB9A
Hydrochloric Acid SCHEMBL2411357 0.89 PPARA (0.37) PPARAMAPTTP53PPARDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026370-B2 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-27 US disclosed
US-8026370-B2 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-27 US disclosed
US-8026370-B2 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-27 US disclosed
US-20080167307-A1 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof MITSUBISHI PHAMA CORPORATION (JP) 2008-07-10 US disclosed
US-20080167307-A1 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof MITSUBISHI PHAMA CORPORATION (JP) 2008-07-10 US disclosed
EP-1816128-A1 CARBOXYLIC ACID DERIVATIVE CONTAINING THIAZOLE RING AND PHARMACEUTICAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2007-08-08 EP disclosed
EP-1816128-A1 CARBOXYLIC ACID DERIVATIVE CONTAINING THIAZOLE RING AND PHARMACEUTICAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2007-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167307-A1 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof PPARA, PPARD, PPARG PPARA 1/4885MAPT 3435/4885TP53 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.